Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trial
Isabel Leroux‐Roels, Paul Willems, Gwenn Waerlop, Yorick Janssens, Jessika Tourneur, Fien De Boever, Jacques Bruhwyler, Azhar Alhatemi, Bart Jacobs, Florence Nicolas, Geert Leroux‐Roels, Alexandre Le Vert
Topics & Concepts
ELISPOTMedicineImmunogenicityPlaceboPopulationInfluenza vaccineImmunologyCohortPeripheral blood mononuclear cellInternal medicineImmune systemVirologyVaccinationT cellBiologyPathologyBiochemistryEnvironmental healthAlternative medicineIn vitroInfluenza Virus Research StudiesImmunotherapy and Immune Responsesvaccines and immunoinformatics approaches